ASCN Ascom Holding AG

Ascom Boosts Its Healthcare Platform with Launch of New Ascom Myco 2 Smart Handset

“The Ascom Healthcare platform is an exceptionally powerful and comprehensive portfolio of intelligent workflow software, systems and clinical applications,” said Ascom CEO Holger Cordes. “And our new Ascom Myco 2 delivers the power of the Ascom Healthcare platform from and between points of care to anywhere. Caregivers across the care continuum can seamlessly link with medical devices, EMRs, laboratories, nurse call systems as well as other healthcare communications and IT infrastructure. It’s a significant step toward closing the information gaps that hinder hospitals worldwide.”

Upon its launch in 2015, the Ascom Myco was the world’s first smartphone purpose-built for Healthcare. “The Ascom Myco was born out of our unrivalled Healthcare communications experience,” commented Ascom EVP of Marketing Francis Schmeer. “With more than 100,000 worldwide healthcare deployments of our various Healthcare portfolio solutions, we are uniquely qualified to see where workflow improvements can be made.”

“Our Healthcare platform”, adds Schmeer, ”including the Ascom Myco 2, drives improvements which can be as simple as more efficiently fulfilling a patient’s request for a blanket to as critical and complex an activity as automatically assembling a response team for a life-threatening event.”

The Ascom Myco 2 features new capabilities such as embedded near-field communication (NFC) and infrared (IR) positioning. These enable ‘tag-and-go’ data updates and sharing between similarly enabled devices and equipment items. They also enable automated ‘nurse presence’ functionality, which automatically logs staff interactions with patients. The Ascom Myco 2 runs on the Android 5.1 Lollipop operating system, and is available in a Google-certified version with access to apps via Google Play.

“State-of-the-art facilities such as the Humber River Hospital in Canada, and the Kuopio hospital in Finland rely on Ascom Myco to better connect clinicians to patients, and to all the information they need in order to spend less time on administrative activities and more on meaningful care,” said Tim Whelehan, President of Ascom North America. “The new Ascom Myco 2 is the optimized mobile platform delivering the full value of our and our clients’ workflow solutions and communications.”

Ascom is presenting the new Ascom Myco 2 at booth 3135 at the HiMSS17 event in Orlando, Florida, February 20-23.

________________________________________________________________________________________________________________

About Ascom

Ascom is a global solutions provider focused on healthcare ICT and mobile workflow solutions. The vision of Ascom is to close digital information gaps allowing for the best possible decisions – anytime and anywhere. Ascom’s mission is to provide mission-critical, real-time solutions for highly mobile, ad hoc, and time-sensitive environments. Ascom uses its unique product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide truly smooth, complete and efficient workflows for healthcare as well as for industry and retail sectors.

Ascom is headquartered in Baar (Switzerland), has subsidiaries in 15 countries and employs around 1,200 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.

________________________________________________________________________________________________________________

EN
21/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ascom Holding AG

 PRESS RELEASE

Ascom ernennt David Hale zum neuen CEO

Ascom ernennt David Hale zum neuen CEO Ad hoc Mitteilung gemäss Art. 53 KRBaar, Schweiz, 9. Dezember 2025 Der Verwaltungsrat der Ascom Holding AG hat David Hale zum neuen CEO der Ascom Holding AG ernannt. David Hale verfügt über einen erstklassigen Leistungsausweis und mehr als zwanzig Jahre Führungserfahrung in der Technologie- und Industriebranche. Er tritt seine Position am 4. Februar 2026 an. Michael Reitermann gibt die Aufgaben des Interim-CEO zu diesem Zeitpunkt ab, bleibt aber weiterhin ordentliches Mitglied des Verwaltungsrats. David Hale verfügt über mehr als 25 Jahre internation...

 PRESS RELEASE

Ascom appoints David Hale as new CEO

Ascom appoints David Hale as new CEO Ad hoc announcement pursuant to Art. 53 LRBaar, Switzerland, December 9, 2025 David Hale, an executive leader with a proven track record and over two decades of technology and industrial expertise, has been appointed by the Board of Directors of Ascom Holding AG as the new CEO of the Ascom Group. David Hale will join Ascom on February 4, 2026. Michael Reitermann will step down as interim CEO at that time and remain an ordinary member of the Board of Directors. David Hale has more than 25 years of international leadership experience in the medical devic...

Ascom Holding AG: 1 director

A director at Ascom Holding AG bought 20,000 shares at 3.435CHF and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

Ascom, Dräger, and B. Braun Launch Silent ICU Solution, a Milestone in...

Ascom, Dräger, and B. Braun Launch Silent ICU Solution, a Milestone in Patient-Centric Critical Care Baar, Switzerland, 28 October 2025 Ascom, in partnership with Dräger and B. Braun, announces the launch of the Silent ICU solution, introduced at the ESICM LIVES 2025 Congress in Munich. This is a major milestone in critical care innovation and marks a new era in healing environment, patient safety, and workflow efficiency for intensive care units (ICUs). The Silent ICU solution is based on full delegation of alarms from the medical devices to the distributed alarm system. The Silent ICU so...

 PRESS RELEASE

Michael Reitermann takes over the operational leadership of the Ascom ...

Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, 18 September 2025Michael Reitermann, Member of the Board of Directors since 2020, and an executive leader with broad experience both in the USA and Europe, has been appointed by the Board of Directors of Ascom Holding AG as Delegate of the Board of Directors and interim CEO. He takes over the operational leadership from Nicolas Vanden Abeele, who decided to leave Ascom after nearly four years as CEO ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch